Chantix Kit
Product Images NDC 63187-618

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 63187-618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chantix 01)

Chemical structure of the active ingredient varenicline tartrate, depicted as a molecular diagram showing the arrangement of atoms and bonds. The image includes a bicyclic core with nitrogen atoms and a tartrate moiety with hydroxyl and carboxyl groups.*

FDA Label Image

Figure 1 (Chantix 02)

A bar chart comparing percentage values across different studies (Study 2 to Study 6) for CHANTIX 1.0 mg BID, a flexible CHANTIX regimen, and Placebo. Each study shows three bars depicting the different treatments, with error bars indicating variability. The y-axis represents percentage values from 0% to 60%, and the x-axis lists the studies. The chart illustrates relative performance outcomes of CHANTIX dosing versus placebo.*

FDA Label Image

Figure 2 (Chantix 03)

A bar chart depicting comparative data from multiple studies (Study 2, Study 3, Study 4, Study 5) showing percentage values for different treatment groups including CHANTIX (varenicline tartrate) at various dosages, bupropion SR, and placebo. The chart includes error bars for variability in measurements across groups.*

FDA Label Image

Figure 3 (Chantix 04)

A line graph comparing the percentage of continuous abstinent individuals over weeks of follow-up between CHANTIX 1.0 mg BID and placebo groups. The x-axis shows non-treatment follow-up in weeks and the y-axis shows percent continuous abstinent, with CHANTIX demonstrating higher abstinence rates over time compared to placebo.*

FDA Label Image

Company Logo (Chantix 05)

FDA Label Image

63187-618-53 (Chantix 07)

Chantix 0.5 mg / 1 mg tablets kit label displays the product strengths and detailed tablet description. It shows the labeler as Proficient Rx LP with NDC 63187-618-53. The label includes dosing clarification and storage instructions, emphasizing the enclosed medication guide. Product ID RC061853 and distribution by Pfizer Labs are noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.